Allergy Therapeutics plc

AGY.L · LSE
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents£12,790£21,676£12,915£13,522
Short-Term Investments£0£0£0£0
Receivables£7,972£8,615£7,823£9,934
Inventory£13,915£11,874£12,744£11,893
Other Curr. Assets£0£0£0£0
Total Curr. Assets£34,677£42,165£33,482£35,349
Property Plant & Equip (Net)£24,258£23,315£23,745£23,392
Goodwill£3,325£3,300£3,317£3,364
Intangibles£931£1,214£1,370£1,626
Long-Term Investments£0£0£0£0
Tax Assets£1,513£0£0£0
Other NC Assets£2,839£2,976£2,913£5,346
Total NC Assets£32,866£30,805£31,345£33,728
Other Assets£0£0£0£0
Total Assets£67,543£72,970£64,827£69,077
Liabilities
Payables£4,491£14,233£4,015£20,088
Short-Term Debt£405£1,954£600£635
Tax Payable£1,427£0£4,734£0
Deferred Revenue£0£0£0£0
Other Curr. Liab.£19,909£8,792£9,578£3,434
Total Curr. Liab.£27,192£26,430£20,545£25,272
LT Debt£53,040£36,959£22,500£948
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£68£369£382£463
Other NC Liab.£10,267£10,756£11,319£8,780
Total NC Liab.£68,544£53,690£40,573£17,343
Other Liabilities£0£0£0£0
Cap. Leases£6,644£7,057£7,888£7,152
Total Liabilities£95,736£80,120£61,118£42,615
Equity
Pref Stock£0£0£0£0
Common Stock£4,766£4,776£4,766£4,776
Retained Earnings-£195,098-£170,087-£198,927-£174,689
AOCI£5,349£1,740£43,231£41,703
Other Equity£2,151£1,782£0£0
Total Equity-£28,193-£7,150£3,709£26,462
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£67,543£72,970£64,827£69,077
Net Debt£40,655£17,237£10,185-£11,939